Aerus Hydroxyl Blaster with ActivePure Technology Unit Testing
Testing was done at MRIGlobal, a 3rd party independent laboratory with no connection to ActivePure or its affiliates. The reduction percentages were measured incrementally over natural degradation of SARS-CoV-2. Outside of control group - over 99.9% reduction of the SARS-CoV-2 virus.
ActivePure Technology has been proven effective against a broad spectrum of clinically relevant pathogens. Every pathogen has a different level of resistance which is outlined in the hierarchy of pathogens below. This hierarchy is used to help predict the ability of a device or chemical to reduce an emerging pathogen. The founding principle, with some exceptions, is that if you are able to demonstrate effectiveness on a higher-class pathogen at the top of the pyramid then there is a presumed level of efficacy against lower-class pathogens at the bottom.
Click here to review our COVID-19 specific test results.